Clinical laboratory International (CLI)
The leading international magazine for Clinical laboratory Equipment for everyone in the in vitro diagnostics field and related disciplines.
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/PorvairPR599-image.jpg
685
476
panglobal
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png
panglobal2022-09-26 06:39:242022-09-26 06:47:26Medical device components that inhibit bacterial growth
Assessment of proliferative activity in breast cancer
, /in Featured Articles /by panglobalApproaches, significance and challenges Cell proliferation is a hallmark of cancer associated with aggressiveness and response to chemotherapy. In breast cancer (BC), assessment of proliferation constitutes the main component of grading and help in management. Herein, we address the most common approaches for BC proliferation assessment, their limitations, and evolving applications to overcome these challenges.
Conjunctival squamous intraepithelial neoplasia
, /in Featured Articles /by panglobalThe in situ stage of conjunctival squamous cell carcinoma is called conjunctival squamous intraepithelial neoplasia (CSIN). The use of terms such as Bowen’s disease and ocular surface squamous neoplasia are discouraged as their meanings vary and are prone to misinterpretation. The severity of squamous epithelial dysplasia is graded by the proportion of involved surface epithelium. […]
Mass spectrometry analysis of protein glycosylation and viral infectivity
, /in Featured Articles /by panglobalThe recent COVID-19 pandemic and race to develop vaccines against the causative agent, severe acute respiratory syndrome coronavirus 2, has reminded us of the important role that protein glycosylation plays in the mechanisms of pathogen infection and host immune response. CLI caught up with Dr Sanda and Dr Campos (both at Team Scientific Service Group […]
Precision Microbiome Profiling: understanding the microbiome to deliver precision medicine
, /in Featured Articles /by panglobalThe impact of the microbiome on a person’s health and disease is only slowly being fully realized. Here Bio-Me introduce themselves and their work to factor in the microbiome to the delivery of precision medicine.